|
Volumn 13, Issue 11, 2005, Pages 950-958
|
Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study.
a a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
2,4 THIAZOLIDINEDIONE DERIVATIVE;
AMYLOID BETA PROTEIN;
ANTIDIABETIC AGENT;
INSULIN;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;
ROSIGLITAZONE;
AGED;
ALZHEIMER DISEASE;
AMNESIA;
ARTICLE;
BLOOD;
CLINICAL TRIAL;
COGNITIVE DEFECT;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
DRUG POTENTIATION;
FEMALE;
HUMAN;
INSULIN RESISTANCE;
LONG TERM MEMORY;
MALE;
MENTAL HEALTH;
MIDDLE AGED;
NEUROPSYCHOLOGICAL TEST;
OUTCOME ASSESSMENT;
PILOT STUDY;
PSYCHOLOGICAL ASPECT;
RANDOMIZED CONTROLLED TRIAL;
RECALL;
AGED;
AGED, 80 AND OVER;
ALZHEIMER DISEASE;
AMNESIA;
AMYLOID BETA-PROTEIN;
COGNITION DISORDERS;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
HYPOGLYCEMIC AGENTS;
INSULIN;
INSULIN RESISTANCE;
MALE;
MENTAL RECALL;
MENTAL STATUS SCHEDULE;
MIDDLE AGED;
NEUROPSYCHOLOGICAL TESTS;
OUTCOME ASSESSMENT (HEALTH CARE);
PILOT PROJECTS;
PPAR GAMMA;
RETENTION (PSYCHOLOGY);
THIAZOLIDINEDIONES;
|
EID: 33644592598
PISSN: 10647481
EISSN: None
Source Type: Journal
DOI: 10.1176/appi.ajgp.13.11.950 Document Type: Article |
Times cited : (589)
|
References (0)
|